Global Cholera Vaccines Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cholera Vaccines market size was valued at US$ 81 million in 2023. With growing demand in downstream market, the Cholera Vaccines is forecast to a readjusted size of US$ 152.1 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Cholera Vaccines market. Cholera Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cholera Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cholera Vaccines market.
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Cholera Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cholera Vaccines market. It may include historical data, market segmentation by Type (e.g., Dukoral, Shanchol), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cholera Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cholera Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cholera Vaccines industry. This include advancements in Cholera Vaccines technology, Cholera Vaccines new entrants, Cholera Vaccines new investment, and other innovations that are shaping the future of Cholera Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cholera Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Cholera Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cholera Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cholera Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cholera Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cholera Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cholera Vaccines market.
Market Segmentation:
Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Cholera Vaccines market size was valued at US$ 81 million in 2023. With growing demand in downstream market, the Cholera Vaccines is forecast to a readjusted size of US$ 152.1 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Cholera Vaccines market. Cholera Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cholera Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cholera Vaccines market.
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Cholera Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cholera Vaccines market. It may include historical data, market segmentation by Type (e.g., Dukoral, Shanchol), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cholera Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cholera Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cholera Vaccines industry. This include advancements in Cholera Vaccines technology, Cholera Vaccines new entrants, Cholera Vaccines new investment, and other innovations that are shaping the future of Cholera Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cholera Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Cholera Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cholera Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cholera Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cholera Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cholera Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cholera Vaccines market.
Market Segmentation:
Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Dukoral
- Shanchol
- Vaxchora
- Others
- Oral
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Shantha Biotechnics Private Limited
- PaxVax, Inc.
- Valneva SE
- Merck and Co., Inc.
- GlaxoSmithKline plc (GSK)
- Astellas Pharma, Inc.
- Pfizer, Inc.
- Emergent BioSolutions, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Takeda Pharmaceutical Co., Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cholera Vaccines Market Size 2019-2030
2.1.2 Cholera Vaccines Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cholera Vaccines Segment by Type
2.2.1 Dukoral
2.2.2 Shanchol
2.2.3 Vaxchora
2.2.4 Others
2.3 Cholera Vaccines Market Size by Type
2.3.1 Cholera Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cholera Vaccines Market Size Market Share by Type (2019-2024)
2.4 Cholera Vaccines Segment by Application
2.4.1 Oral
2.4.2 Others
2.5 Cholera Vaccines Market Size by Application
2.5.1 Cholera Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cholera Vaccines Market Size Market Share by Application (2019-2024)
3 CHOLERA VACCINES MARKET SIZE BY PLAYER
3.1 Cholera Vaccines Market Size Market Share by Players
3.1.1 Global Cholera Vaccines Revenue by Players (2019-2024)
3.1.2 Global Cholera Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Cholera Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHOLERA VACCINES BY REGIONS
4.1 Cholera Vaccines Market Size by Regions (2019-2024)
4.2 Americas Cholera Vaccines Market Size Growth (2019-2024)
4.3 APAC Cholera Vaccines Market Size Growth (2019-2024)
4.4 Europe Cholera Vaccines Market Size Growth (2019-2024)
4.5 Middle East & Africa Cholera Vaccines Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cholera Vaccines Market Size by Country (2019-2024)
5.2 Americas Cholera Vaccines Market Size by Type (2019-2024)
5.3 Americas Cholera Vaccines Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cholera Vaccines Market Size by Region (2019-2024)
6.2 APAC Cholera Vaccines Market Size by Type (2019-2024)
6.3 APAC Cholera Vaccines Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cholera Vaccines by Country (2019-2024)
7.2 Europe Cholera Vaccines Market Size by Type (2019-2024)
7.3 Europe Cholera Vaccines Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cholera Vaccines by Region (2019-2024)
8.2 Middle East & Africa Cholera Vaccines Market Size by Type (2019-2024)
8.3 Middle East & Africa Cholera Vaccines Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CHOLERA VACCINES MARKET FORECAST
10.1 Global Cholera Vaccines Forecast by Regions (2025-2030)
10.1.1 Global Cholera Vaccines Forecast by Regions (2025-2030)
10.1.2 Americas Cholera Vaccines Forecast
10.1.3 APAC Cholera Vaccines Forecast
10.1.4 Europe Cholera Vaccines Forecast
10.1.5 Middle East & Africa Cholera Vaccines Forecast
10.2 Americas Cholera Vaccines Forecast by Country (2025-2030)
10.2.1 United States Cholera Vaccines Market Forecast
10.2.2 Canada Cholera Vaccines Market Forecast
10.2.3 Mexico Cholera Vaccines Market Forecast
10.2.4 Brazil Cholera Vaccines Market Forecast
10.3 APAC Cholera Vaccines Forecast by Region (2025-2030)
10.3.1 China Cholera Vaccines Market Forecast
10.3.2 Japan Cholera Vaccines Market Forecast
10.3.3 Korea Cholera Vaccines Market Forecast
10.3.4 Southeast Asia Cholera Vaccines Market Forecast
10.3.5 India Cholera Vaccines Market Forecast
10.3.6 Australia Cholera Vaccines Market Forecast
10.4 Europe Cholera Vaccines Forecast by Country (2025-2030)
10.4.1 Germany Cholera Vaccines Market Forecast
10.4.2 France Cholera Vaccines Market Forecast
10.4.3 UK Cholera Vaccines Market Forecast
10.4.4 Italy Cholera Vaccines Market Forecast
10.4.5 Russia Cholera Vaccines Market Forecast
10.5 Middle East & Africa Cholera Vaccines Forecast by Region (2025-2030)
10.5.1 Egypt Cholera Vaccines Market Forecast
10.5.2 South Africa Cholera Vaccines Market Forecast
10.5.3 Israel Cholera Vaccines Market Forecast
10.5.4 Turkey Cholera Vaccines Market Forecast
10.5.5 GCC Countries Cholera Vaccines Market Forecast
10.6 Global Cholera Vaccines Forecast by Type (2025-2030)
10.7 Global Cholera Vaccines Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Shantha Biotechnics Private Limited
11.1.1 Shantha Biotechnics Private Limited Company Information
11.1.2 Shantha Biotechnics Private Limited Cholera Vaccines Product Offered
11.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Shantha Biotechnics Private Limited Main Business Overview
11.1.5 Shantha Biotechnics Private Limited Latest Developments
11.2 PaxVax, Inc.
11.2.1 PaxVax, Inc. Company Information
11.2.2 PaxVax, Inc. Cholera Vaccines Product Offered
11.2.3 PaxVax, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PaxVax, Inc. Main Business Overview
11.2.5 PaxVax, Inc. Latest Developments
11.3 Valneva SE
11.3.1 Valneva SE Company Information
11.3.2 Valneva SE Cholera Vaccines Product Offered
11.3.3 Valneva SE Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Valneva SE Main Business Overview
11.3.5 Valneva SE Latest Developments
11.4 Merck and Co., Inc.
11.4.1 Merck and Co., Inc. Company Information
11.4.2 Merck and Co., Inc. Cholera Vaccines Product Offered
11.4.3 Merck and Co., Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck and Co., Inc. Main Business Overview
11.4.5 Merck and Co., Inc. Latest Developments
11.5 GlaxoSmithKline plc (GSK)
11.5.1 GlaxoSmithKline plc (GSK) Company Information
11.5.2 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Offered
11.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline plc (GSK) Main Business Overview
11.5.5 GlaxoSmithKline plc (GSK) Latest Developments
11.6 Astellas Pharma, Inc.
11.6.1 Astellas Pharma, Inc. Company Information
11.6.2 Astellas Pharma, Inc. Cholera Vaccines Product Offered
11.6.3 Astellas Pharma, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Astellas Pharma, Inc. Main Business Overview
11.6.5 Astellas Pharma, Inc. Latest Developments
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Information
11.7.2 Pfizer, Inc. Cholera Vaccines Product Offered
11.7.3 Pfizer, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Pfizer, Inc. Main Business Overview
11.7.5 Pfizer, Inc. Latest Developments
11.8 Emergent BioSolutions, Inc.
11.8.1 Emergent BioSolutions, Inc. Company Information
11.8.2 Emergent BioSolutions, Inc. Cholera Vaccines Product Offered
11.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Emergent BioSolutions, Inc. Main Business Overview
11.8.5 Emergent BioSolutions, Inc. Latest Developments
11.9 Mitsubishi Tanabe Pharma Corporation
11.9.1 Mitsubishi Tanabe Pharma Corporation Company Information
11.9.2 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Offered
11.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mitsubishi Tanabe Pharma Corporation Main Business Overview
11.9.5 Mitsubishi Tanabe Pharma Corporation Latest Developments
11.10 Takeda Pharmaceutical Co., Ltd.
11.10.1 Takeda Pharmaceutical Co., Ltd. Company Information
11.10.2 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Offered
11.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Pharmaceutical Co., Ltd. Main Business Overview
11.10.5 Takeda Pharmaceutical Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cholera Vaccines Market Size 2019-2030
2.1.2 Cholera Vaccines Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cholera Vaccines Segment by Type
2.2.1 Dukoral
2.2.2 Shanchol
2.2.3 Vaxchora
2.2.4 Others
2.3 Cholera Vaccines Market Size by Type
2.3.1 Cholera Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cholera Vaccines Market Size Market Share by Type (2019-2024)
2.4 Cholera Vaccines Segment by Application
2.4.1 Oral
2.4.2 Others
2.5 Cholera Vaccines Market Size by Application
2.5.1 Cholera Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cholera Vaccines Market Size Market Share by Application (2019-2024)
3 CHOLERA VACCINES MARKET SIZE BY PLAYER
3.1 Cholera Vaccines Market Size Market Share by Players
3.1.1 Global Cholera Vaccines Revenue by Players (2019-2024)
3.1.2 Global Cholera Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Cholera Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHOLERA VACCINES BY REGIONS
4.1 Cholera Vaccines Market Size by Regions (2019-2024)
4.2 Americas Cholera Vaccines Market Size Growth (2019-2024)
4.3 APAC Cholera Vaccines Market Size Growth (2019-2024)
4.4 Europe Cholera Vaccines Market Size Growth (2019-2024)
4.5 Middle East & Africa Cholera Vaccines Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cholera Vaccines Market Size by Country (2019-2024)
5.2 Americas Cholera Vaccines Market Size by Type (2019-2024)
5.3 Americas Cholera Vaccines Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cholera Vaccines Market Size by Region (2019-2024)
6.2 APAC Cholera Vaccines Market Size by Type (2019-2024)
6.3 APAC Cholera Vaccines Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cholera Vaccines by Country (2019-2024)
7.2 Europe Cholera Vaccines Market Size by Type (2019-2024)
7.3 Europe Cholera Vaccines Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cholera Vaccines by Region (2019-2024)
8.2 Middle East & Africa Cholera Vaccines Market Size by Type (2019-2024)
8.3 Middle East & Africa Cholera Vaccines Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CHOLERA VACCINES MARKET FORECAST
10.1 Global Cholera Vaccines Forecast by Regions (2025-2030)
10.1.1 Global Cholera Vaccines Forecast by Regions (2025-2030)
10.1.2 Americas Cholera Vaccines Forecast
10.1.3 APAC Cholera Vaccines Forecast
10.1.4 Europe Cholera Vaccines Forecast
10.1.5 Middle East & Africa Cholera Vaccines Forecast
10.2 Americas Cholera Vaccines Forecast by Country (2025-2030)
10.2.1 United States Cholera Vaccines Market Forecast
10.2.2 Canada Cholera Vaccines Market Forecast
10.2.3 Mexico Cholera Vaccines Market Forecast
10.2.4 Brazil Cholera Vaccines Market Forecast
10.3 APAC Cholera Vaccines Forecast by Region (2025-2030)
10.3.1 China Cholera Vaccines Market Forecast
10.3.2 Japan Cholera Vaccines Market Forecast
10.3.3 Korea Cholera Vaccines Market Forecast
10.3.4 Southeast Asia Cholera Vaccines Market Forecast
10.3.5 India Cholera Vaccines Market Forecast
10.3.6 Australia Cholera Vaccines Market Forecast
10.4 Europe Cholera Vaccines Forecast by Country (2025-2030)
10.4.1 Germany Cholera Vaccines Market Forecast
10.4.2 France Cholera Vaccines Market Forecast
10.4.3 UK Cholera Vaccines Market Forecast
10.4.4 Italy Cholera Vaccines Market Forecast
10.4.5 Russia Cholera Vaccines Market Forecast
10.5 Middle East & Africa Cholera Vaccines Forecast by Region (2025-2030)
10.5.1 Egypt Cholera Vaccines Market Forecast
10.5.2 South Africa Cholera Vaccines Market Forecast
10.5.3 Israel Cholera Vaccines Market Forecast
10.5.4 Turkey Cholera Vaccines Market Forecast
10.5.5 GCC Countries Cholera Vaccines Market Forecast
10.6 Global Cholera Vaccines Forecast by Type (2025-2030)
10.7 Global Cholera Vaccines Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Shantha Biotechnics Private Limited
11.1.1 Shantha Biotechnics Private Limited Company Information
11.1.2 Shantha Biotechnics Private Limited Cholera Vaccines Product Offered
11.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Shantha Biotechnics Private Limited Main Business Overview
11.1.5 Shantha Biotechnics Private Limited Latest Developments
11.2 PaxVax, Inc.
11.2.1 PaxVax, Inc. Company Information
11.2.2 PaxVax, Inc. Cholera Vaccines Product Offered
11.2.3 PaxVax, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PaxVax, Inc. Main Business Overview
11.2.5 PaxVax, Inc. Latest Developments
11.3 Valneva SE
11.3.1 Valneva SE Company Information
11.3.2 Valneva SE Cholera Vaccines Product Offered
11.3.3 Valneva SE Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Valneva SE Main Business Overview
11.3.5 Valneva SE Latest Developments
11.4 Merck and Co., Inc.
11.4.1 Merck and Co., Inc. Company Information
11.4.2 Merck and Co., Inc. Cholera Vaccines Product Offered
11.4.3 Merck and Co., Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck and Co., Inc. Main Business Overview
11.4.5 Merck and Co., Inc. Latest Developments
11.5 GlaxoSmithKline plc (GSK)
11.5.1 GlaxoSmithKline plc (GSK) Company Information
11.5.2 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Offered
11.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline plc (GSK) Main Business Overview
11.5.5 GlaxoSmithKline plc (GSK) Latest Developments
11.6 Astellas Pharma, Inc.
11.6.1 Astellas Pharma, Inc. Company Information
11.6.2 Astellas Pharma, Inc. Cholera Vaccines Product Offered
11.6.3 Astellas Pharma, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Astellas Pharma, Inc. Main Business Overview
11.6.5 Astellas Pharma, Inc. Latest Developments
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Information
11.7.2 Pfizer, Inc. Cholera Vaccines Product Offered
11.7.3 Pfizer, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Pfizer, Inc. Main Business Overview
11.7.5 Pfizer, Inc. Latest Developments
11.8 Emergent BioSolutions, Inc.
11.8.1 Emergent BioSolutions, Inc. Company Information
11.8.2 Emergent BioSolutions, Inc. Cholera Vaccines Product Offered
11.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Emergent BioSolutions, Inc. Main Business Overview
11.8.5 Emergent BioSolutions, Inc. Latest Developments
11.9 Mitsubishi Tanabe Pharma Corporation
11.9.1 Mitsubishi Tanabe Pharma Corporation Company Information
11.9.2 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Offered
11.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mitsubishi Tanabe Pharma Corporation Main Business Overview
11.9.5 Mitsubishi Tanabe Pharma Corporation Latest Developments
11.10 Takeda Pharmaceutical Co., Ltd.
11.10.1 Takeda Pharmaceutical Co., Ltd. Company Information
11.10.2 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Offered
11.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Pharmaceutical Co., Ltd. Main Business Overview
11.10.5 Takeda Pharmaceutical Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cholera Vaccines Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Dukoral
Table 3. Major Players of Shanchol
Table 4. Major Players of Vaxchora
Table 5. Major Players of Others
Table 6. Cholera Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 9. Cholera Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 12. Global Cholera Vaccines Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Cholera Vaccines Revenue Market Share by Player (2019-2024)
Table 14. Cholera Vaccines Key Players Head office and Products Offered
Table 15. Cholera Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cholera Vaccines Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Cholera Vaccines Market Size Market Share by Regions (2019-2024)
Table 20. Global Cholera Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Cholera Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Cholera Vaccines Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Cholera Vaccines Market Size Market Share by Country (2019-2024)
Table 24. Americas Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 26. Americas Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 28. APAC Cholera Vaccines Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Cholera Vaccines Market Size Market Share by Region (2019-2024)
Table 30. APAC Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 32. APAC Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 34. Europe Cholera Vaccines Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Cholera Vaccines Market Size Market Share by Country (2019-2024)
Table 36. Europe Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 38. Europe Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Cholera Vaccines Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Cholera Vaccines Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Cholera Vaccines
Table 47. Key Market Challenges & Risks of Cholera Vaccines
Table 48. Key Industry Trends of Cholera Vaccines
Table 49. Global Cholera Vaccines Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Cholera Vaccines Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Cholera Vaccines Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Cholera Vaccines Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Shantha Biotechnics Private Limited Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 54. Shantha Biotechnics Private Limited Cholera Vaccines Product Offered
Table 55. Shantha Biotechnics Private Limited Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Shantha Biotechnics Private Limited Main Business
Table 57. Shantha Biotechnics Private Limited Latest Developments
Table 58. PaxVax, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 59. PaxVax, Inc. Cholera Vaccines Product Offered
Table 60. PaxVax, Inc. Main Business
Table 61. PaxVax, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. PaxVax, Inc. Latest Developments
Table 63. Valneva SE Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 64. Valneva SE Cholera Vaccines Product Offered
Table 65. Valneva SE Main Business
Table 66. Valneva SE Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Valneva SE Latest Developments
Table 68. Merck and Co., Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 69. Merck and Co., Inc. Cholera Vaccines Product Offered
Table 70. Merck and Co., Inc. Main Business
Table 71. Merck and Co., Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Merck and Co., Inc. Latest Developments
Table 73. GlaxoSmithKline plc (GSK) Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 74. GlaxoSmithKline plc (GSK) Cholera Vaccines Product Offered
Table 75. GlaxoSmithKline plc (GSK) Main Business
Table 76. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GlaxoSmithKline plc (GSK) Latest Developments
Table 78. Astellas Pharma, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 79. Astellas Pharma, Inc. Cholera Vaccines Product Offered
Table 80. Astellas Pharma, Inc. Main Business
Table 81. Astellas Pharma, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Astellas Pharma, Inc. Latest Developments
Table 83. Pfizer, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 84. Pfizer, Inc. Cholera Vaccines Product Offered
Table 85. Pfizer, Inc. Main Business
Table 86. Pfizer, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Pfizer, Inc. Latest Developments
Table 88. Emergent BioSolutions, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 89. Emergent BioSolutions, Inc. Cholera Vaccines Product Offered
Table 90. Emergent BioSolutions, Inc. Main Business
Table 91. Emergent BioSolutions, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Emergent BioSolutions, Inc. Latest Developments
Table 93. Mitsubishi Tanabe Pharma Corporation Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 94. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Offered
Table 95. Mitsubishi Tanabe Pharma Corporation Main Business
Table 96. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Mitsubishi Tanabe Pharma Corporation Latest Developments
Table 98. Takeda Pharmaceutical Co., Ltd. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 99. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Offered
Table 100. Takeda Pharmaceutical Co., Ltd. Main Business
Table 101. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Takeda Pharmaceutical Co., Ltd. Latest Developments
Table 1. Cholera Vaccines Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Dukoral
Table 3. Major Players of Shanchol
Table 4. Major Players of Vaxchora
Table 5. Major Players of Others
Table 6. Cholera Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 9. Cholera Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 12. Global Cholera Vaccines Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Cholera Vaccines Revenue Market Share by Player (2019-2024)
Table 14. Cholera Vaccines Key Players Head office and Products Offered
Table 15. Cholera Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cholera Vaccines Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Cholera Vaccines Market Size Market Share by Regions (2019-2024)
Table 20. Global Cholera Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Cholera Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Cholera Vaccines Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Cholera Vaccines Market Size Market Share by Country (2019-2024)
Table 24. Americas Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 26. Americas Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 28. APAC Cholera Vaccines Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Cholera Vaccines Market Size Market Share by Region (2019-2024)
Table 30. APAC Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 32. APAC Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 34. Europe Cholera Vaccines Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Cholera Vaccines Market Size Market Share by Country (2019-2024)
Table 36. Europe Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 38. Europe Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Cholera Vaccines Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Cholera Vaccines Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Cholera Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cholera Vaccines Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Cholera Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Cholera Vaccines Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Cholera Vaccines
Table 47. Key Market Challenges & Risks of Cholera Vaccines
Table 48. Key Industry Trends of Cholera Vaccines
Table 49. Global Cholera Vaccines Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Cholera Vaccines Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Cholera Vaccines Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Cholera Vaccines Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Shantha Biotechnics Private Limited Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 54. Shantha Biotechnics Private Limited Cholera Vaccines Product Offered
Table 55. Shantha Biotechnics Private Limited Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Shantha Biotechnics Private Limited Main Business
Table 57. Shantha Biotechnics Private Limited Latest Developments
Table 58. PaxVax, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 59. PaxVax, Inc. Cholera Vaccines Product Offered
Table 60. PaxVax, Inc. Main Business
Table 61. PaxVax, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. PaxVax, Inc. Latest Developments
Table 63. Valneva SE Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 64. Valneva SE Cholera Vaccines Product Offered
Table 65. Valneva SE Main Business
Table 66. Valneva SE Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Valneva SE Latest Developments
Table 68. Merck and Co., Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 69. Merck and Co., Inc. Cholera Vaccines Product Offered
Table 70. Merck and Co., Inc. Main Business
Table 71. Merck and Co., Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Merck and Co., Inc. Latest Developments
Table 73. GlaxoSmithKline plc (GSK) Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 74. GlaxoSmithKline plc (GSK) Cholera Vaccines Product Offered
Table 75. GlaxoSmithKline plc (GSK) Main Business
Table 76. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GlaxoSmithKline plc (GSK) Latest Developments
Table 78. Astellas Pharma, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 79. Astellas Pharma, Inc. Cholera Vaccines Product Offered
Table 80. Astellas Pharma, Inc. Main Business
Table 81. Astellas Pharma, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Astellas Pharma, Inc. Latest Developments
Table 83. Pfizer, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 84. Pfizer, Inc. Cholera Vaccines Product Offered
Table 85. Pfizer, Inc. Main Business
Table 86. Pfizer, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Pfizer, Inc. Latest Developments
Table 88. Emergent BioSolutions, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 89. Emergent BioSolutions, Inc. Cholera Vaccines Product Offered
Table 90. Emergent BioSolutions, Inc. Main Business
Table 91. Emergent BioSolutions, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Emergent BioSolutions, Inc. Latest Developments
Table 93. Mitsubishi Tanabe Pharma Corporation Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 94. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Offered
Table 95. Mitsubishi Tanabe Pharma Corporation Main Business
Table 96. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Mitsubishi Tanabe Pharma Corporation Latest Developments
Table 98. Takeda Pharmaceutical Co., Ltd. Details, Company Type, Cholera Vaccines Area Served and Its Competitors
Table 99. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Offered
Table 100. Takeda Pharmaceutical Co., Ltd. Main Business
Table 101. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Takeda Pharmaceutical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Cholera Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cholera Vaccines Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cholera Vaccines Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cholera Vaccines Sales Market Share by Country/Region (2023)
Figure 8. Cholera Vaccines Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cholera Vaccines Market Size Market Share by Type in 2023
Figure 10. Cholera Vaccines in Oral
Figure 11. Global Cholera Vaccines Market: Oral (2019-2024) & ($ Millions)
Figure 12. Cholera Vaccines in Others
Figure 13. Global Cholera Vaccines Market: Others (2019-2024) & ($ Millions)
Figure 14. Global Cholera Vaccines Market Size Market Share by Application in 2023
Figure 15. Global Cholera Vaccines Revenue Market Share by Player in 2023
Figure 16. Global Cholera Vaccines Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Cholera Vaccines Market Size 2019-2024 ($ Millions)
Figure 18. APAC Cholera Vaccines Market Size 2019-2024 ($ Millions)
Figure 19. Europe Cholera Vaccines Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Cholera Vaccines Market Size 2019-2024 ($ Millions)
Figure 21. Americas Cholera Vaccines Value Market Share by Country in 2023
Figure 22. United States Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Cholera Vaccines Market Size Market Share by Region in 2023
Figure 27. APAC Cholera Vaccines Market Size Market Share by Type in 2023
Figure 28. APAC Cholera Vaccines Market Size Market Share by Application in 2023
Figure 29. China Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Cholera Vaccines Market Size Market Share by Country in 2023
Figure 36. Europe Cholera Vaccines Market Size Market Share by Type (2019-2024)
Figure 37. Europe Cholera Vaccines Market Size Market Share by Application (2019-2024)
Figure 38. Germany Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Cholera Vaccines Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Cholera Vaccines Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Cholera Vaccines Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 52. APAC Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 53. Europe Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 55. United States Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 56. Canada Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 59. China Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 60. Japan Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 61. Korea Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 63. India Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 64. Australia Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 65. Germany Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 66. France Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 67. UK Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 68. Italy Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 69. Russia Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 70. Spain Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 73. Israel Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 76. Global Cholera Vaccines Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Cholera Vaccines Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Cholera Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cholera Vaccines Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cholera Vaccines Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cholera Vaccines Sales Market Share by Country/Region (2023)
Figure 8. Cholera Vaccines Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cholera Vaccines Market Size Market Share by Type in 2023
Figure 10. Cholera Vaccines in Oral
Figure 11. Global Cholera Vaccines Market: Oral (2019-2024) & ($ Millions)
Figure 12. Cholera Vaccines in Others
Figure 13. Global Cholera Vaccines Market: Others (2019-2024) & ($ Millions)
Figure 14. Global Cholera Vaccines Market Size Market Share by Application in 2023
Figure 15. Global Cholera Vaccines Revenue Market Share by Player in 2023
Figure 16. Global Cholera Vaccines Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Cholera Vaccines Market Size 2019-2024 ($ Millions)
Figure 18. APAC Cholera Vaccines Market Size 2019-2024 ($ Millions)
Figure 19. Europe Cholera Vaccines Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Cholera Vaccines Market Size 2019-2024 ($ Millions)
Figure 21. Americas Cholera Vaccines Value Market Share by Country in 2023
Figure 22. United States Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Cholera Vaccines Market Size Market Share by Region in 2023
Figure 27. APAC Cholera Vaccines Market Size Market Share by Type in 2023
Figure 28. APAC Cholera Vaccines Market Size Market Share by Application in 2023
Figure 29. China Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Cholera Vaccines Market Size Market Share by Country in 2023
Figure 36. Europe Cholera Vaccines Market Size Market Share by Type (2019-2024)
Figure 37. Europe Cholera Vaccines Market Size Market Share by Application (2019-2024)
Figure 38. Germany Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Cholera Vaccines Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Cholera Vaccines Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Cholera Vaccines Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Cholera Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 52. APAC Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 53. Europe Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 55. United States Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 56. Canada Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 59. China Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 60. Japan Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 61. Korea Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 63. India Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 64. Australia Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 65. Germany Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 66. France Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 67. UK Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 68. Italy Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 69. Russia Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 70. Spain Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 73. Israel Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Cholera Vaccines Market Size 2025-2030 ($ Millions)
Figure 76. Global Cholera Vaccines Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Cholera Vaccines Market Size Market Share Forecast by Application (2025-2030)
